InsiderTrades

Form 4 for TDOC Teladoc Health, Inc.

Accepted 2025-03-21 00:00:00 ET · period of report 2025-03-19 · accession 0001477449-25-000035 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-21 2025-03-19 TDOC Murthy Mala CFO M - OptEx — +36.9K 136.9K +37% —
D 2025-03-21 2025-03-20 TDOC Murthy Mala CFO S - Sale+OE $8.42 -20.6K 116.3K -15% -$173.3K
D 2025-03-21 2025-03-19 TDOC Murthy Mala CFO M - OptEx $0.00 -36.9K 73.9K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-19 M A 36,933 — 136,895 D — — (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2 Common Common Stock 2025-03-20 S D 20,586 $8.42 116,309 D — — (F2) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
3 Derivative Restricted Stock Units 2025-03-19 M D 36,933 $0.00 73,867 D — · — to — 36,933 Common Stock (F1) Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. (F3) One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.